Nvidia helping create 'self-driving MRI' | GE finalizes $2.3B Intelerad deal | New real-world evidence on lung screening AI

GE previously noted that the acquisition was a reflection of the company’s “continued commitment to cloud-enabled and AI-powered solutions.” 

Though the study of AI in lung cancer screening is not new, prior research has been retrospective in nature, making it challenging to determine the impact. 

AI in medical imaging market analyst Umar Ahmed from Signify Research explains some of the key trends seen in radiology artificial intelligence. 

The hope is that the new service will open the door for patients to undergo treatment and diagnostic exams locally instead of having to travel long distances. 

The Amsterdam-based imaging giant is working with the AI powerhouse to create an AI-generated preview of MRI scans, before the acquisition even begins. 

TerraPower Isotopes is building a flagship factory in the Bellwether District of Philadelphia, which will eventually produce actinium-225. 

The Bedford, Massachusetts-based drugmaker announced the news on March 17, with the three-month delay pertaining to LNTH-2501. 

Market forces like competition cannot stem the urge to merge among and between payers and providers, so neither will they staunch the price hikes in premiums. 

A new Doximity survey shows 94% of American physicians using AI or at least keen on it. Just as tellingly, the pace of adoption is brisk and accelerating. 

The Center for Medicare and Medicaid Innovation (CMMI) has tested nearly 40 APMs, of which only two turned out to be successful, which does not bode well for meeting a 2030 deadline to transition to value-based payments.